All posts by IOM Topic: Quality and Patient Safety

Workshop on Glutamate-related Biomarkers in Drug Development for Disorders of the Nervous System

The goal of the workshop was to present promising current and emerging technologies with potential as reliable glutamate biomarkers, and to outline strategies to accelerate development, validation, and implementation of these biomarkers as powerful tools to advance drug development for nervous system disorders associated with glutamatergic dysfunction.


Comprehensive Cancer Care for Children and their Families

Through invited presentations and panel discussions, this workshop hosted by the NCPF and the American Cancer Society (ACS) will examine recent trends in comprehensive cancer care for pediatric cancer patients and their families and consider potential policy actions to improve care and outcomes. Participants will review existing evidence and efforts for integrating pediatric palliative care and quality of life strategies in childhood oncology research and practice, and will discuss additional research needed to minimize toxicities of pediatric cancer treatments and the resultant symptoms and late effects. A major goal of the workshop will be to facilitate discussion about potential strategies and actions for effectively applying existing evidence and quality of life strategies into pediatric oncology research, development, and practice. More

Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life

A substantial body of evidence shows that broad improvements to end-of-life care are within reach. In Dying in America, a consensus report from the Institute of Medicine (IOM), a committee of experts finds that improving the quality and availability of medical and social services for patients and their families could not only enhance quality of life through the end of life, but may also contribute to a more sustainable care system.


Standing Committee on Credentialing Research in Nursing

The Institute of Medicine will convene a standing committee for the American Nurses Credentialing Center. The standing committee will discuss issues related to research on credentialing of nurses and organizations including short- and long-term strategic planning. The standing committee will maintain surveillance of the field, discuss planning and program development, and serve as a focal point for discussions and potential ad hoc studies requested by the sponsor and approved by the Institute of Medicine and the National Academies.


Strategies for Responsible Sharing of Clinical Trial Data

Clinical trials are a crucial part of the development process for new medical innovations. They are used to investigate the safety and efficacy of new therapeutics, medical devices, biologics, or procedures; determine the patient population where novel products will have the greatest positive effect; or provide detailed information on the therapeutic experience of individual patients. These trials represent a significant investment from all involved—patients who volunteer to participate, organizations that sponsor trials, and the researchers who conduct a study and analyze the data—with the resultant data being used to determine whether a medical product or procedure has the potential to improve the health of individuals. More